Evidence map›Paper›PMID 42289440›Full record

ArticleScientific reports2026

A computational model to describe multi-regional brain architecture during neurodegeneration in Alzheimer's disease.

Xingfeng Li, Andrea G Rockall, Paul Edison, Alzheimer’s Disease Neuroimaging Initiative (ADNI), Australian Imaging Biomarkers and Lifestyle (AIBL) Study, Eric O Aboagye

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xingfeng LiDepartment of Surgery and Cancer, Imperial College Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.
Andrea G RockallDepartment of Surgery and Cancer, Imperial College Hammersmith Campus, Du Cane Road, London, W12 0NN, UK.
Paul EdisonImperial College Memory Research Centre, Department of Brain Science, Imperial College Healthcare NHS Trust, UK Hammersmith Hospital, Du Cane Road, London, W12 0HS, UK.
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Australian Imaging Biomarkers and Lifestyle (AIBL) Study
Eric O AboagyeDepartment of Surgery and Cancer, Imperial College Hammersmith Campus, Du Cane Road, London, W12 0NN, UK. eric.aboagye@imperial.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We previously proposed an MRI-based machine learning model to describe the mesoscopic architecture of the human brain to aid in classifying subjects as having non-AD related pathology (nADrp) or AD related pathology (ADrp), including mild cognitive impairment (MCI) and Alzheimer's disease (AD). The method, developed on data from patients scanned at 1.5T showed high performance, but did not generalise well to scans obtained from 3T MRI. In the current work we overcome the problem and extend the approach to patients scanned longitudinally, and at different field strengths. Retrospective T1-MRI data from 1592 subjects scanned at 3T were included to develop the machine learning models. Three additional longitudinal datasets (n = 211) at different magnetic field strengths-1.5 and 3T-were adopted to evaluate the models. Radiomic features were extracted from each brain region. A logistic regression method with least absolute shrinkage and selection operator (LASSO) model selection was employed to classify nADrp from ADrp (classifier 1) or MCI from AD (classifier 2). Classifier 1 that discriminates nADrp from ADrp achieves high performance, with area under the curve (AUC) of the receiver operating characteristics (ROC) of 0.84 in the independent hold-out cross-sectional dataset. High performance was also seen in external testing datasets for classifier 1 (AUC of 0.70 to 0.96). Classifier 2 that discriminates MCI from AD achieves AUC of 0.79 in the independent hold-out dataset and moderate to good performance in the external testing datasets (AUC of 0.56 to 0.93). The new data analysis methods, trained on 3T data, demonstrate potential for aiding AD early detection and disease progression on both 3T and 1.5T scanners.

Indexed as

Alzheimer DiseaseBrainAgedAged, 80 and overCognitive DysfunctionComputer SimulationDisease ProgressionFemaleHumansMachine LearningMagnetic Resonance ImagingMaleRadiomicsRetrospective StudiesAlzheimer’s diseaseFeature selectionLongitudinal studyMachine learning classificationMild cognitive impairment (MCI)MRI radiomics

Identifiers

PMID42289440
PMCPMC13527134

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.